As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
National Institutes of Health
Collaborating Institutions
Triterpenoid Therapeutics Inc
For this proposal, we will be responsible for the experiments involving infection of K18 hACE2 mice with SARS-CoV-2 USA-WA1/2020 strain and assess the effectivity of a drug compound provided by the partnering company.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Zhang, Guoquan
Funded by
NIH Natl Inst of Allergy/Infectious Dise
Coxiella burnetii is an obligate intracellular gram-negative bacterium that causes acute Q fever and chronic infections in humans. Since there is no licensed vaccine for prevention of human Q fever in the US. the development of safe and effective prophylactic and therapeutic strategies for controlling C. burnetii infection remains an important goal for public health. However. there is a fundamental gap in the knowledge regarding the mechanisms of host immune response to C. burnetii natural infection.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
This major goal of this funding is to outfit the Pathology Unit of SNPRC with a new chemistry analyzer, a new slide stainer and coverslipper, as well as seeks to purchase a state of the art whole slide scanner, which will provide a significant upgrade to research capabilities supported by Texas Biomed.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Janssen Pharmaceuticals, Inc.
The major goal of this study is to evaluate the cellular immune response in macaques vaccinated with an anti-heme vaccine.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
Bill & Melinda Gates Foundation
The overall scope of the study is to determine if human monoclonal antibodies (hmAbs) shown in vitro to block SARS-CoV-2 infection are also effective, alone or in combination, in vivo using two rodent animal models of SARS-CoV-2 infection and associated COVID-19 disease.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Liu, Aimin
Funded by
NIH Natl Inst General Medical Sci
This application is a request of the administrative supplement funds to the above parent grant to support a Hispanic graduate student. Mr. Samuel L. Montoya. for his graduate study in the Department of Chemistry at The University of Texas at San Antonio. A 24-month of financial support is budgeted for providing Mr. Montoya with salaries. tuition support. health insurance. and support of research-related training activities such as workshops and scientific conferences.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Turner, Joanne
Funded by
National Institutes of Health
The major goal of the project is to understand COVID-19 in the elderly for the development of cures or vaccines.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Janssen Pharmaceuticals, Inc.
This project is a pilot study to demonstrate that ELISPOT assays are performing adequately.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Shtanko, Olena
Funded by
Wellcome Trust
Collaborating Institutions
Intervir RX
For this proposal, we will assess three compounds for antiviral activity in a cell-based Lassa virus infection assay.